Takeda Pharmaceutical - Stock Price History | TAK

Historical daily share price chart and data for Takeda Pharmaceutical since 2020 adjusted for splits. The latest closing stock price for Takeda Pharmaceutical as of July 10, 2020 is 17.27.
  • The all-time high Takeda Pharmaceutical stock closing price was 21.52 on March 21, 2019.
  • The Takeda Pharmaceutical 52-week high stock price is 20.93, which is 21.2% above the current share price.
  • The Takeda Pharmaceutical 52-week low stock price is 12.43, which is 28% below the current share price.
  • The average Takeda Pharmaceutical stock price for the last 52 weeks is 18.12.
Takeda Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 18.6715 16.8200 21.5200 16.1500 19.7300 17.30%
2018 16.9425 17.2600 17.2600 16.7400 16.8200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $54.479B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.390B 37.11
Astellas Pharma (ALPMY) Japan $29.584B 14.99
Eisai (ESALY) Japan $24.627B 21.35
UCB SA (UCBJF) Belgium $23.856B 0.00
Merck (MKGAF) Germany $16.075B 21.08
Grifols, S.A (GRFS) Spain $12.802B 15.91
Catalent (CTLT) United States $12.260B 47.40
Neurocrine Biosciences (NBIX) United States $12.217B 56.46
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.421B 44.77
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.936B 31.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.837B 9.34
United Therapeutics (UTHR) United States $5.146B 9.75
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.595B 501.67
Nektar Therapeutics (NKTR) United States $4.348B 0.00
Evotec AG (EVTCY) Germany $4.090B 110.22
Hypermarcas (HYPMY) Brazil $3.793B 13.95
FibroGen (FGEN) United States $3.726B 0.00
PTC Therapeutics (PTCT) United States $3.724B 0.00
ChemoCentryx (CCXI) United States $3.654B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.493B 10.24
Pacira BioSciences (PCRX) United States $2.423B 49.59
Sage Therapeutics (SAGE) United States $2.290B 0.00
Cronos Group (CRON) Canada $2.100B 60.20
Corcept Therapeutics (CORT) United States $1.920B 19.03
Xencor (XNCR) United States $1.821B 0.00
USANA Health Sciences (USNA) United States $1.725B 17.69
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.719B 0.00
Akebia Therapeutics (AKBA) United States $1.628B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Indivior (INVVY) United States $1.556B 19.31
Zogenix (ZGNX) United States $1.539B 0.00
Esperion Therapeutics (ESPR) United States $1.428B 0.00
Heron Therapeutics (HRTX) United States $1.419B 0.00
Karyopharm Therapeutics (KPTI) United States $1.378B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.351B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.306B 14.06
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.080B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.022B 45.63
BioCryst Pharmaceuticals (BCRX) United States $0.975B 0.00
Tilray (TLRY) Canada $0.925B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
Endo (ENDP) Ireland $0.772B 1.20
Radius Health (RDUS) United States $0.616B 0.00
VAXART, INC (VXRT) United States $0.608B 0.00
Trillium Therapeutics (TRIL) Canada $0.603B 0.00
Aerie Pharmaceuticals (AERI) United States $0.603B 0.00
Molecular Templates (MTEM) United States $0.596B 0.00
Collegium Pharmaceutical (COLL) United States $0.589B 0.00
Ardelyx (ARDX) United States $0.587B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.558B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.519B 12.55
Crinetics Pharmaceuticals (CRNX) United States $0.512B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 18.35
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.425B 0.00
Harpoon Therapeutics (HARP) United States $0.403B 0.00
TherapeuticsMD (TXMD) United States $0.399B 0.00
Ocular Therapeutix (OCUL) United States $0.398B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.386B 0.00
Calithera Biosciences (CALA) United States $0.368B 0.00
MEI Pharma (MEIP) United States $0.365B 0.00
Organogenesis Holdings (ORGO) United States $0.352B 0.00
Altimmune (ALT) United States $0.314B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.287B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.286B 0.00
Taiwan Liposome (TLC) Taiwan $0.256B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.47
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Redhill Biopharma (RDHL) Israel $0.242B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 5.19
KalVista Pharmaceuticals (KALV) United States $0.216B 0.00
Rafael Holdings (RFL) United States $0.196B 0.00
OptiNose (OPTN) United States $0.195B 0.00
IMV INC (IMV) Canada $0.181B 0.00
Nivalis Therapeutics (ALPN) United States $0.176B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 23.08
Aquestive Therapeutics (AQST) United States $0.152B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.134B 0.00
Otonomy (OTIC) United States $0.119B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.102B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Xeris Pharmaceuticals (XERS) United States $0.097B 0.00
CTI BioPharma (CTIC) United States $0.095B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Hemispherx BioPharma (AIM) United States $0.087B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Sundial Growers (SNDL) Canada $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Heat Biologics (HTBX) United States $0.079B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Lipocine (LPCN) United States $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.09
PolarityTE (PTE) United States $0.048B 0.00
IsoRay (ISR) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 7.56
Opiant Pharmaceuticals (OPNT) United States $0.040B 84.54
Novan (NOVN) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.038B 0.00
GTx (ONCT) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.14
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00